<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171017036837N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-09-18</date_registration>
      <primary_sponsor>Vice Chancellery of Research and Technology</primary_sponsor>
      <public_title>The effect of continues and every another day physical therapy on pain and function in subjects with knee osteoarthritis.</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effect of continues and intermittent physical therapy on amount of pain and function in subjects with moderate knee osteoarthritis (pilot randomized clinical trial)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-08-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/32713</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Tools used in randomization (throwing coin), Blinding description: Treatments are done by the researcher and evaluations are done by another assessor. The assessor doesn't know about patients grouping.The patients don't know about their group and other groups. since the treatment component was exactly the same in both groups except the frequency of sessions. the participants knew that they will receive standard physical therapy to determine its effect in Iranian subjects. Both groups truly receive standard intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 3 times a week, for 10 sessions every another day will be done. Conventional physiotherapy treatment includes these: 1. Transcutaneous electrical nerve stimulation(TENS): 10HZ, 250 microsecond, 20 minutes, four electrodes medial and lateral to the superior and inferior poles of the patella 2. Hot moist pack for 20 minute 3. Ultrasound: 1 MHz, 2 Watt, 5 minutes, continuous(1-2 minute per 10 cm2) with circular motion covering medial, lateral and anterior aspects of the target knee joint. 4. Quadriceps setting 5. VMO setting. Intervention 2: Control group: 6 times a week, for 10 sessions every day will be done. Conventional physiotherapy treatment includes these: 1. Transcutaneous electrical nerve stimulation(TENS): 10HZ, 250 microsecond, 20 minutes, four electrodes medial and lateral to the superior and inferior poles of the patella 2. Hot moist pack for 20 minute 3. Ultrasound: 1 MHz, 2 Watt, 5 minutes, continuous(1-2 minute per 10 cm2) with circular motion covering medial, lateral and anterior aspects of the target knee joint. 4. Quadriceps setting 5. VMO setting.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sayed Mohsen Mirbod</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jerib Street</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3669 3089</telephone>
        <email>mirbod@rehab.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sayed Mohsen Mirbod</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezar Jerib Street</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3669 3089</telephone>
        <email>mirbod@rehab.mui.ac.i</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients with primary knee osteoarthritis
Having criteria of knee osteoarthritis according to American college of rheumatology
Patients with grade 2 or 3  Kellgren-lawrence scale of moderate knee osteoarthritis
Age more than 40 years
Not being in the acute phase of the disease
Able to write and read
Men and women with moderate knee osteoarthritis
Body mass index less than 35</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Systemic rheumatoid arthritis
Secondary knee osteoarthritis
Active knee synovitis
Severe knee trauma
Surgery intervention on knee during 1 year ago
Intra-articular injection of corticosteroids or hyaluronic acid for at least the last 6 months
Performing a physiotherapy treatment in the last 3 months
Taking of Non steroidal anti-inflammatory drug from a week before entering the study
Musculoskeletal disorders in lower extrimities
Disorders in lumbopelvic and hip region
Bilateral involvement of knees which one of them is grade 4 Kellgren-lawrence scale</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 3 times a week, for 10 sessions every another day will be done. Conventional physiotherapy treatment includes these: 1. Transcutaneous electrical nerve stimulation(TENS): 10HZ, 250 microsecond, 20 minutes, four electrodes medial and lateral to the superior and inferior poles of the patella 2. Hot moist pack for 20 minute 3. Ultrasound: 1 MHz, 2 Watt, 5 minutes, continuous(1-2 minute per 10 cm2) with circular motion covering medial, lateral and anterior aspects of the target knee joint. 4. Quadriceps setting 5. VMO setting</i_keyword>
      <i_keyword>Control group: 6 times a week, for 10 sessions every day will be done. Conventional physiotherapy treatment includes these: 1. Transcutaneous electrical nerve stimulation(TENS): 10HZ, 250 microsecond, 20 minutes, four electrodes medial and lateral to the superior and inferior poles of the patella 2. Hot moist pack for 20 minute 3. Ultrasound: 1 MHz, 2 Watt, 5 minutes, continuous(1-2 minute per 10 cm2) with circular motion covering medial, lateral and anterior aspects of the target knee joint. 4. Quadriceps setting 5. VMO setting</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: One day before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Function. Timepoint: One day before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Get up and go test.</prim_outcome>
      <prim_outcome>Pain. Timepoint: One day before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Knee injury and osteoarthritis outcome score.</prim_outcome>
      <prim_outcome>Pain. Timepoint: One day before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Intermittent and constant osteoarthritis pain.</prim_outcome>
      <prim_outcome>Function. Timepoint: One day before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Six minute walk test.</prim_outcome>
      <prim_outcome>Function. Timepoint: One day before the intervention and at the tenth session after the end of the treatment plan. Method of measurement: Knee injury and osteoarthritis outcome score.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice Chancellery of Research and Technology</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-09-11</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences.</contact_name>
        <contact_address>Secretariat of the Ethics Committee, Room 209, Second Floor, Building No. 4, Isfahan University of Medical Sciences, Hezar Jerib Street Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
